EMBRYOTROPIC PROPERTIES OF A NEW COMPOSITION OF FENBENDAZOLE AND ALBENDAZOLE (PANAVERM PLUS)

The drug Panaverm plus administered at the doses of 10,0; 15,0; 25,0; 35,0 and 45,0 mg/kg body weight (by 4.5 times increased dose) showed no embryotropic activity. Panaverm plus used at the dose of 55,0 mg / kg body weight did not cause changes in the development  of embryos, except  one case of hy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. M. Bittirov, S. J. Begiev, A. A. Bittirova, S. Sh. Kabardiev, L. H. Eldarova, Z. G. Musayev
Formato: Artigo
Idioma:Russo
Publicado em: Federal Scientific Centre VIEV 2016-05-01
Colecção:Российский паразитологический журнал
Assuntos:
embryotropic properties
new composition
fenbendazole
albendazole
panаverm plus
biosafety
toxicity
teratogenicity
mutagenicity
Acesso em linha:https://vniigis.elpub.ru/jour/article/view/176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados